Cargando…
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
The cell fate determinant Numb is frequently downregulated in human breast cancers (BCs), resulting in p53 inactivation and an aggressive disease course. In the mouse mammary gland, Numb/p53 downregulation leads to aberrant tissue morphogenesis, expansion of the stem cell compartment, and emergence...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412856/ https://www.ncbi.nlm.nih.gov/pubmed/28298340 http://dx.doi.org/10.15252/emmm.201606940 |